Skip to main content
FinSpry Logo
FinSpry
PGNY logo
PGNY
(NASDAQ)
Progyny, Inc.
$26.28-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Progyny (PGNY) Stock Price & Financial Analysis

Progyny Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$26.25 - $26.93
52-Week High$28.75
52-Week Low$16.10
Open$26.43
Volume1.92M
Average Volume (3M)1.73M
Market Cap2.21B
Shares Outstanding84.76M
P/E Ratio (TTM)32.65
Forward P/E26.45
Price to Sales (P/S)1.71
Price to Book (P/B)5.03
EV/EBITDA19.42
Revenue (TTM)1.29B
Net Income (TTM)67.69M
Free Cash Flow (TTM)184.42M
EPS (TTM)$0.76
Profit Margin5.23%
Operating Margin7.46%
Return on Equity (ROE)15.41%
Debt to Equity0.06
50-Day MA$22.15
200-Day MA$22.08
52-Week Change20.46%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About Progyny

What is the current stock price for PGNY?

As of the latest trading session, PGNY stock trades at $26.28. The 52-week range is $16.10–$28.75, with a day range of $26.25–$26.93.

What is the P/E ratio for PGNY?

Progyny's trailing P/E ratio is 32.6, meaning investors pay $32.6 for every $1 of annual earnings. The forward P/E is 26.4, reflecting analyst expectations for future earnings. Progyny operates in the Healthcare sector.

Does PGNY pay dividends?

Progyny does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for PGNY?

Based on 8 analysts, the consensus for PGNY is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of PGNY?

Progyny's market capitalization is $2.23B, classifying it as a mid-cap company. Progyny operates in the Healthcare sector within the Healthcare Plans industry.